Spencer Pharmaceutical Inc.
OTC: SPPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Maximilien Arella
- Employees
- 2
- Headquarters
- Boston, United States
- IPO year
- 2023
- Market cap
- $29.4K
- Website
- https://www.spencerpharmaceutical.com
Loading SPPH…
Loading profile data…Frequently asked questions about SPPH
What does Spencer Pharmaceutical Inc. (SPPH) do?
Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms aimed at addressing neurological conditions. A core aspect of their expertise lies in the precise, controlled administration of existing therapeutic compounds for central nervous system disorders, such as Alzheimer's, Parkinson's disease, and various forms of brain ca...
Where does SPPH trade?
Spencer Pharmaceutical Inc. (SPPH) trades on the Other OTC.
What sector is SPPH in?
Spencer Pharmaceutical Inc. (SPPH) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Spencer Pharmaceutical Inc.?
Maximilien Arella is the chief executive officer of Spencer Pharmaceutical Inc. (SPPH).
Where is Spencer Pharmaceutical Inc. headquartered?
Spencer Pharmaceutical Inc. is headquartered in United States.
Does SPPH pay a dividend?
Spencer Pharmaceutical Inc. (SPPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SPPH go public?
Spencer Pharmaceutical Inc. (SPPH) completed its initial public offering in 2023.